InvestorsHub Logo
Followers 82
Posts 3648
Boards Moderated 0
Alias Born 02/15/2010

Re: blu_1 post# 57174

Thursday, 03/17/2016 6:17:45 PM

Thursday, March 17, 2016 6:17:45 PM

Post# of 458548
How do you know that Dr. Missling has all the data?

A week ago he didn't have all of it -

“Safety is a key requirement for a potential drug approval and we believe that this extension, which is now already the second of this trial, is an important step forward for patients, caregivers and physicians, who have asked for continued access to ANAVEX 2-73,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “While we are waiting for longitudinal effect data of ANAVEX 2-73 over an extended period of time, the positive dose-response in PART A is an encouraging step and also consistent with the fast mode of action of the sigma-1 receptor.“

http://www.anavex.com/?news=anavex-announces-two-year-clinical-extension-study-of-anavex-2-73-and-presents-phase-2a-dose-response-analysis-at-aat-conference

Why you guys nitpicking and hanging on every word Missling says? Insinuating the stock will drop if 12 week isn't revealed by end of qtr? If you're gonna nitpick, then why aren't you freaking out now b/c Missling said Anavex would reveal 12,26 and 52 week results as they become available and we all know the 12 week results are available now and could be revealed.


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News